Abstract 6741: Tertiary lymphoid structure (TLS)-associated immune circuits define response to durvalumab, trastuzumab, and pertuzumab (DTP) in HER2-enriched early breast cancer
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Houston Methodist
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148832807
Cites:
Cited by:
Related to: